TAM
TMO icon

Trillium Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Trillium Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16M Sell
31,849
-28,675
-47% -$13.8M 0.49% 65
2026
Q1 		$16.5M Buy
60,524
+26,585
+78% +$14.4M 0.55% 60
2025
Q4 		$19.9M Sell
33,939
-2,881
-8% -$1.63M 0.61% 54
2025
Q3 		$17.9M Sell
36,820
-38,005
-51% -$17.7M 0.47% 64
2025
Q2 		$30.3M Sell
74,825
-5,439
-7% -$2.27M 0.82% 36
2025
Q1 		$39.9M Sell
80,264
-3,065
-4% -$1.66M 1.15% 25
2024
Q4 		$43.4M Sell
83,329
-4,366
-5% -$2.4M 1.12% 18
2024
Q3 		$54.2M Sell
87,695
-1,761
-2% -$1.04M 1.33% 13
2024
Q2 		$49.5M Sell
89,456
-3,241
-3% -$1.86M 1.25% 16
2024
Q1 		$53.9M Sell
92,697
-253
-0.3% -$142K 1.37% 14
2023
Q4 		$49.3M Buy
92,950
+1,135
+1% +$549K 1.34% 15
2023
Q3 		$46.5M Buy
91,815
+1,112
+1% +$593K 1.4% 12
2023
Q2 		$47.3M Buy
90,703
+9,178
+11% +$4.95M 1.33% 15
2023
Q1 		$45.3M Buy
81,525
+1,621
+2% +$914K 1.33% 20
2022
Q4 		$44M Sell
79,904
-45
-0.1% -$23.8K 1.35% 17
2022
Q3 		$40.5M Buy
79,949
+2,386
+3% +$1.34M 1.33% 16
2022
Q2 		$42.4M Buy
77,563
+8,993
+13% +$4.95M 1.3% 17
2022
Q1 		$40.5M Buy
68,570
+31,359
+84% +$18M 1.08% 25
2021
Q4 		$24.8M Buy
37,211
+1,231
+3% +$769K 0.58% 65
2021
Q3 		$20.6M Buy
35,980
+16,887
+88% +$9.27M 0.54% 69
2021
Q2 		$9.59M Buy
19,093
+2,298
+14% +$1.08M 0.26% 96
2021
Q1 		$7.66M Buy
16,795
+4,932
+42% +$2.35M 0.24% 102
2020
Q4 		$5.53M Buy
+11,863
New +$5.56M 0.2% 106
2019
Q4 		– Sell
-1,262
Closed -$367K – 273
2019
Q3 		$367K Buy
+1,262
New +$361K 0.02% 222
2013
Q4 		– Sell
-4,269
Closed -$393K – 188
2013
Q3 		$393K Buy
+4,269
New +$386K 0.04% 161

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Trillium Asset Management's TMO Position: Q2 2026 in Review

Trillium Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 47% in Q2 2026, selling an estimated $13.8M and leaving 31,849 shares worth $16M. The position accounts for 0.49% of the portfolio, ranked #65.

Trillium Asset Management first reported a position in TMO in Q3 2013 and has held it in 25 quarters since. The position peaked at $54.2M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Trillium Asset Management held 31,849 shares of Thermo Fisher Scientific worth $16M as of Q2 2026.
  • Trillium Asset Management sold 28,675 Thermo Fisher Scientific shares in Q2 2026, an estimated $13.8M.
  • Thermo Fisher Scientific made up 0.49% of Trillium Asset Management's portfolio in Q2 2026, its #65 holding.
  • Trillium Asset Management first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 25 quarters since.
  • Trillium Asset Management's Thermo Fisher Scientific position peaked at $54.2M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Trillium Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.